Christof Fellmann

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 9

Top Topics

Dna Methylation

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Nature communications

Nature biotechnology

Science (New York, N.Y.)

This page only lists publications with an associated author ORCID identifier.

Publications

Arik Shams, Sean A Higgins, Christof Fellmann, Thomas G Laughlin, Benjamin L Oakes, Rachel Lew, Shin Kim, Maria Lukarska, Madeline Arnold, Brett T Staahl, Jennifer A Doudna, David F Savage
Comprehensive deletion landscape of CRISPR-Cas9 identifies minimal RNA-guided DNA-binding modules. Nature communications 12 (1) (2021)
Alexandra M Amen, Christof Fellmann, Katarzyna M Soczek, Shawn M Ren, Rachel J Lew, Gavin J Knott, Jesslyn E Park, Andrew M McKinney, Andrew Mancini, Jennifer A Doudna, Joseph F Costello
Cancer-specific loss of TERT activation sensitizes glioblastoma to DNA damage. Proceedings of the National Academy of Sciences of the United States of America 118 (13) (2021)
Kyle E Watters, Haridha Shivram, Christof Fellmann, Rachel J Lew, Blake McMahon, Jennifer A Doudna
Potent CRISPR-Cas9 inhibitors from Staphylococcus genomes. Proceedings of the National Academy of Sciences of the United States of America 117 (12) (2020)
Chih-Shia Lee, Liam C Lee, Tina L Yuan, Sirisha Chakka, Christof Fellmann, Scott W Lowe, Natasha J Caplen, Frank McCormick, Ji Luo
MAP kinase and autophagy pathways cooperate to maintain RAS mutant cancer cell survival. Proceedings of the National Academy of Sciences of the United States of America 116 (10) (2019)
Kale Kundert, James E Lucas, Kyle E Watters, Christof Fellmann, Andrew H Ng, Benjamin M Heineike, Christina M Fitzsimmons, Benjamin L Oakes, Jiuxin Qu, Neha Prasad, Oren S Rosenberg, David F Savage, Hana El-Samad, Jennifer A Doudna, Tanja Kortemme
Controlling CRISPR-Cas9 with ligand-activated and ligand-deactivated sgRNAs. Nature communications 10 (1) (2019)
Gavin J Knott, Brady F Cress, Jun-Jie Liu, Brittney W Thornton, Rachel J Lew, Basem Al-Shayeb, Daniel J Rosenberg, Michal Hammel, Benjamin A Adler, Marco J Lobba, Michael Xu, Adam Paul Arkin, Christof Fellmann, Jennifer A Doudna
Structural basis for AcrVA4 inhibition of specific CRISPR-Cas12a. eLife 8 (2019)
Tony P Huang, Kevin Tianmeng Zhao, Shannon M Miller, Nicole M Gaudelli, Benjamin L Oakes, Christof Fellmann, David F Savage, David R Liu
Circularly permuted and PAM-modified Cas9 variants broaden the targeting scope of base editors. Nature biotechnology 37 (6) (2019)
Kyle E Watters, Christof Fellmann, Hua B Bai, Shawn M Ren, Jennifer A Doudna
Systematic discovery of natural CRISPR-Cas12a inhibitors. Science (New York, N.Y.) 362 (6411) (2018)
Hyo Min Park, Hui Liu, Joann Wu, Anthony Chong, Vanessa Mackley, Christof Fellmann, Anirudh Rao, Fuguo Jiang, Hunghao Chu, Niren Murthy, Kunwoo Lee
Extension of the crRNA enhances Cpf1 gene editing in vitro and in vivo. Nature communications 9 (1) (2018)